2-Epicucurbitacin B

CAS No. 59015-72-4

2-Epicucurbitacin B( ——— )

Catalog No. M38362 CAS No. 59015-72-4

2-epi-Cucurbitacin B is a natural product that can be obtained from Ecballium elaterium L. XVI..

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    2-Epicucurbitacin B
  • Note
    Research use only, not for human use.
  • Brief Description
    2-epi-Cucurbitacin B is a natural product that can be obtained from Ecballium elaterium L. XVI..
  • Description
    2-epi-Cucurbitacin B is a natural product that can be obtained from Ecballium elaterium L. XVI.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    59015-72-4
  • Formula Weight
    558.7
  • Molecular Formula
    C32H46O8
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lavie D, et al. The Constituents of Ecballium elaterium L. XVI. Stereochemical Problems in the Cucurbitacins1, 2. The Journal of Organic Chemistry, 1963, 28(7): 1790-1795.
molnova catalog
related products
  • 4-Cyclohexylphenol

    4-Cyclohexylphenol is a biochemical compound for proteomics research.

  • (3S,5S)-1-(4-Hydroxy...

    (3S,5S)-1-(4-Hydroxy-3-methoxyphenyl)-7-phenyl-3,5-heptanediol is a heptane compound that can be isolated from Alpinia oxyphylla.

  • 5-Methyluridine

    Ribothymidine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents.